Aarti Pharmalabs Ltd
NSE:AARTIPHARM
Wall Street
Price Targets
AARTIPHARM Price Targets Summary
Aarti Pharmalabs Ltd
According to Wall Street analysts, the average 1-year price target for AARTIPHARM is 984.3 INR with a low forecast of 974.65 INR and a high forecast of 1 013.25 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AARTIPHARM's stock price target?
Price Target
984.3
INR
According to Wall Street analysts, the average 1-year price target for AARTIPHARM is 984.3 INR with a low forecast of 974.65 INR and a high forecast of 1 013.25 INR.
What is Aarti Pharmalabs Ltd's Revenue forecast?
Projected CAGR
-50%
For the last 3 years the compound annual growth rate for Aarti Pharmalabs Ltd's revenue is 21%. The projected CAGR for the next 3 years is -50%.
What is Aarti Pharmalabs Ltd's Operating Income forecast?
Projected CAGR
-51%
For the last 3 years the compound annual growth rate for Aarti Pharmalabs Ltd's operating income is 6%. The projected CAGR for the next 3 years is -51%.
What is Aarti Pharmalabs Ltd's Net Income forecast?
Projected CAGR
6%
For the last 3 years the compound annual growth rate for Aarti Pharmalabs Ltd's net income is 31%. The projected CAGR for the next 3 years is 6%.
